An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

In the U.S. in the early 1960s the distributor of a thalidomide drug was impatient to get it on the market. But FDA medical ...

Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare ...

A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic telangiectasia (HHT), a rare bleeding disorder that impacts more than 1 in ...

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those ...

The company behind the deposit return scheme is facing an action for discrimination by a disability advocate, who claims that ...

Severe nosebleeds caused by hereditary hemorrhagic telangiectasia dwinded in people who took a drug used to treat cancer.

Brisbane: Nobody wants to see another Thalidomide tragedy. The drug was prescribed to pregnant women during the 1950s and early 1960s to treat nausea. But it led to more than 10,000 children worldwide ...

The legacy of Thalidomide continues to impact how medications are prescribed to pregnant women today. Ethical concerns, legal ...

Excluding pregnant women from drug trials is standard. But medication use during pregnancy has gone up, and many women are ...